Skip to main content

Interventional Cardiology Market is Increasing at a Perfect CAGR of 5.4% During Forecast to 2025


Market Analysis:

Various factors are adding to the global interventional cardiology market share. These factors, as per the new MRFR report, include increasing geriatric population, preference for minimally invasive procedures, growing awareness created by key players and medical professionals regarding the benefits of interventional cardiology procedures, increasing investment in R&D, incorporation of innovations in cardiac intervention industries, collaborations and partnerships between local players and key players, support by government organizations, and favorable reimbursement scenario especially in developed countries. Besides, increasing cases of cardiac disease and technological advances in interventional cardiac devices are also adding to the interventional cardiology devices market growth. 

The Interventional Cardiology Market Size was valued USD 15,130.75 million in 2018 and is predicted to grow at a 5.4% CAGR between 2019- 2025, reveals the new Market Research Future (MRFR) report. Interventional cardiology, simply put, is a branch of cardiology that deals with structural heart disease treatment that is catheter-based. 


On the contrary, the risk of bloodstream infections and product recalls are factors that may limit the interventional cardiology market growth over the forecast period. 

Key Players:

W. L. Gore & Associates, Inc. (US), Terumo Corporation (Japan), Merit Medical Systems, Inc (US), Medtronic (Ireland), Life Vascular Devices Biotech S.L. (Spain), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Edwards Lifesciences Corporation (US), Cook Medical (US), Cardinal Health (US), Boston Scientific Corporation (US), Biotronik SE & Co. KG (Germany), Biosense Webster, Inc (US), BD (US), B. Braun Melsungen AG (Germany), ACIST Medical Systems, Inc. (the US), Abbott (US), and ABIOMED (US). 

Market Segmentation:

·         The Market Research Future Report provides an inclusive segmental analysis of the global interventional cardiology market based on end user and type. 

·         By type, the interventional cardiology market is segmented into coronary guidewires, plaque modification devices, percutaneous transluminal coronary angioplasty (PTCA) catheters, stents, and accessories. Stents are again segmented into bioresorbable vascular scaffolds, bare-metal stents, and drug-eluting stents. PTCA catheters are again segmented into guiding catheters and balloon catheters. Of these, the stents segment will lead the market over the forecast period for the rising number of product launches by industry players lately, constant innovation by players, and rising cases of coronary artery disease. 

·         By end user, the interventional cardiology market is segmented into ambulatory surgical centers, cardiac catheterization laboratories, hospitals, and others. Of these, hospitals will spearhead the market over the forecast period for the increase in patient admissions in hospitals for coronary diseases. This will be followed by the cardiac catheterization laboratory segment, which is likely to grow at a fast pace for its rising preference by medical professionals. 

Regional Analysis:
Based on the region, the global interventional cardiology market report covers the recent trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East & Africa (RoW). Of these, the Americas will spearhead the market over the forecast period for the rising prevalence of coronary diseases in the region. Besides, the presence of top market players is also adding market growth. 

The interventional cardiology market in Europe is predicted to possess the second-largest share over the forecast period for the rising number of hospitalizations for cerebral angioplasty and carotid artery angioplasty. 

The interventional cardiology market in the APAC region is predicted to grow at a fast pace over the forecast period for an increasing number of collaborations and partnerships, rising number of setups of R&D centers, robust marketing initiatives undertaken by the manufacturers, and consumers helping to increase the target audience. 

The interventional cardiology market in the MEA is predicted to hold the smallest share over the forecast period yet is likely to grow owing to the focus of industry players on untapped regions. 


NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.


Labels:

Comments

Post a Comment

Popular posts from this blog

Covid 19 Analysis on Medical Devices and Accessories Market is Growing at a Healthy CAGR of 6.53% During Forecast to 2023

Market Insights: Medical devices and accessories refer to any apparatus, machine, instrument used for the treatment of disease and illness through monitoring, diagnosis, and treatment. Growing occurrences of chronic diseases and diabetes, geriatric population, rising cases of surgical cases, healthcare expenditure, and technological advancements for superior medical infrastructures, and constant investments by industry giants are some of the pointers that might help the global medical device and accessories market to flourish during the forecast period. Market Research Future stated that the global Covid 19 Analysis on Medical Devices and Accessories Market Growth is estimated to register a CAGR of 6.53%, reaching the valuation of USD 133,835.9 , during the forecast period, 2014-2023 . Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/5466 Other additional factors influencing the growth of the global market include mergers and collaboration led by the...
Post a Comment
Read more

BRIC Diabetes Treatment and Prevention Market is Supposed to Gain at a Fruitful CAGR of 11.52% During Forecast to 2023

Market Highlights Diabetes drugs are the drugs which are administered for the treatment of different types of Diabetes. The prevalence of diabetes is on the rise due to increased life expectancy, changing lifestyles, and the rising incidence of obesity. Diabetes can be kept in control with the help of medication, exercise and controlled diet.  Diabetes Prevention Industry in BRICS is expected to reach  USD 9.45 billion  by 2023 at a CAGR of 11.52%   during forecast period 2017 to 2023. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/1323 Test the market data and market information presented through more than 45 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Diabetes treatment and prevention market Research Report –BRICS Forecast to 2023.” BRICS diabetes treatment and prevention market players: Key players in diabetes treatment...
Post a Comment
Read more

Fluoroscopy and Mobile C-Arms Market is Substantially Gaining at a CAGR of 4.58% During Forecast to 2023

Market Overview: The increasing prevalence of chronic diseases is expected to have a significant impact on the fluoroscopy and mobile c-arms market. The market is also being encouraged by the massive geriatric population present globally. The increased pace of development in the healthcare sector is also anticipated to motivate the fluoroscopy and mobile c-arms market in the coming forecast period. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/7717 Fluoroscopy can be defined as an imaging technique, which uses X-Ray technology for taking real-time images of the body. It allows the physicians to visualize muscles, organs, and bones, which further helps them to make crucial decisions during surgery. The global Fluoroscopy And Mobile C-Arms Market Growth as per a report by Market Research Future (MRFR) is touted to register a CAGR of 4.58%, surpassing a valuation of USD 2,951.4 million during the forecast period. Competitive Dashboard: Canon Medical ...
Post a Comment
Read more